Latest Period
Q1 2026
Security Snapshot
PDS Biotechnology Corp - Common (PDSB) Institutional Ownership
CUSIP: 70465T107
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
39
Shares (Excl. Options)
5,046,836
Price
$0.60
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common
- Symbol
- PDSB on Nasdaq
- Shares outstanding
- 49,594,356
- Price per share
- $0.93
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 5,046,836
- Total reported value
- $3,053,148
- % of total 13F portfolios
- 0%
- Share change
- -2,833,364
- Value change
- -$1,761,034
- Number of holders
- 39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- PDSB - PDS Biotechnology Corp - Common is tracked under CUSIP 70465T107.
- 39 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 42 to 39 between Q4 2025 and Q1 2026.
- Reported value moved from $6,066,657 to $3,053,148.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 39 institutions filings for Q1 2026.
Security key
70465T107
Latest holder period
Q1 2026
13F holders
39
13D/G owners
0
CIK / CUSIP context first
Open Q1 2026 holders
PDSB full holder history
PDS Biotechnology Corp SEC filings
PDS Biotechnology Corp company facts
PDS Biotechnology Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 70465T107:
As of 31 Mar 2026, 39 institutional investors reported holding 5,046,836 shares of PDS Biotechnology Corp - Common (PDSB). This represents 10% of the company’s total 49,594,356 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of PDS Biotechnology Corp - Common (PDSB) together control 10% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 1,631,089 | 0% | 0% | $986,809 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 660,228 | +27% | 0% | $399,489 |
| BlackRock, Inc. | 1.1% | 554,048 | +6.1% | 0% | $335,199 |
| VANGUARD FIDUCIARY TRUST CO | 0.62% | 307,311 | 0% | 0% | $185,923 |
| BLAIR WILLIAM & CO/IL | 0.6% | 300,000 | +20% | 0% | $181,500 |
| RENAISSANCE TECHNOLOGIES LLC | 0.45% | 220,800 | +25% | 0% | $133,584 |
| INSPIRION WEALTH ADVISORS, LLC | 0.37% | 181,995 | +0.83% | 0.01% | $110,107 |
| ARMISTICE CAPITAL, LLC | 0.35% | 173,605 | -94% | 0% | $105,031 |
| STATE STREET CORP | 0.27% | 133,333 | 0% | 0% | $80,666 |
| WELLS FARGO & COMPANY/MN | 0.22% | 110,500 | +1974% | 0% | $66,853 |
| NORTHERN TRUST CORP | 0.22% | 108,893 | -24% | 0% | $65,880 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.18% | 90,797 | -54% | 0% | $54,930 |
| Iron Gate Global Advisors LLC | 0.15% | 75,022 | +0.01% | 0% | $45,388 |
| Bank of New York Mellon Corp | 0.14% | 69,310 | -0% | 0% | $41,933 |
| NINE MASTS CAPITAL Ltd | 0.14% | 67,507 | 0.01% | $40,842 | |
| Tempus Wealth Planning, LLC | 0.12% | 61,800 | 0% | 0.01% | $37,389 |
| UBS Group AG | 0.11% | 56,004 | -78% | 0% | $33,882 |
| XTX Topco Ltd | 0.07% | 36,211 | +5.8% | 0% | $21,908 |
| TWO SIGMA SECURITIES, LLC | 0.06% | 31,481 | 0% | $19,046 | |
| ACT CAPITAL MANAGEMENT, LLC | 0.06% | 30,000 | 0% | 0.01% | $18,150 |
| Rockefeller Capital Management L.P. | 0.06% | 27,664 | +7.8% | 0% | $16,737 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 22,052 | -43% | 0% | $13,341 |
| Federation des caisses Desjardins du Quebec | 0.03% | 14,800 | 0% | 0% | $8,954 |
| Wealth Group, Ltd. | 0.03% | 13,399 | 0% | 0.01% | $8,000 |
| Vanguard Global Advisers, LLC | 0.03% | 12,546 | 0% | 0% | $7,590 |
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 5,046,836 | $3,053,148 | -$1,761,034 | $0.60 | 39 |
| 2025 Q4 | 7,880,200 | $6,066,657 | +$1,624,175 | $0.77 | 42 |
| 2025 Q3 | 5,620,337 | $6,638,921 | -$1,895,965 | $1.01 | 47 |
| 2025 Q2 | 7,451,352 | $9,901,943 | -$1,043,791 | $1.33 | 55 |
| 2025 Q1 | 8,226,452 | $9,789,276 | +$4,484,828 | $1.19 | 46 |
| 2024 Q4 | 4,239,917 | $6,914,602 | -$572,034 | $1.63 | 51 |
| 2024 Q3 | 4,325,988 | $16,519,540 | -$3,544,953 | $3.82 | 56 |
| 2024 Q2 | 5,489,394 | $16,083,121 | -$6,957,012 | $2.93 | 73 |
| 2024 Q1 | 7,611,671 | $30,140,536 | -$4,107,493 | $3.96 | 69 |
| 2023 Q4 | 8,335,087 | $41,487,859 | +$2,355,421 | $4.97 | 74 |
| 2023 Q3 | 7,861,668 | $39,699,832 | -$403,816 | $5.05 | 78 |
| 2023 Q2 | 7,931,948 | $39,898,006 | -$317,214 | $5.03 | 80 |
| 2023 Q1 | 7,611,967 | $46,811,436 | +$1,184,438 | $6.15 | 66 |
| 2022 Q4 | 6,820,799 | $90,031,703 | +$24,029,740 | $13.20 | 63 |
| 2022 Q3 | 5,178,399 | $15,378,000 | -$458,535 | $2.97 | 42 |
| 2022 Q2 | 5,251,472 | $19,171,000 | -$3,835,298 | $3.65 | 46 |
| 2022 Q1 | 5,851,637 | $36,220,000 | -$1,228,374 | $6.19 | 49 |
| 2021 Q4 | 5,916,212 | $47,919,000 | -$12,229,786 | $8.10 | 63 |
| 2021 Q3 | 6,752,518 | $100,597,635 | +$11,330,602 | $14.90 | 58 |
| 2021 Q2 | 5,941,843 | $74,429,183 | +$40,638,979 | $12.55 | 41 |
| 2021 Q1 | 3,145,310 | $14,311,158 | +$1,348,464 | $4.55 | 29 |
| 2020 Q4 | 3,132,654 | $6,703,955 | -$487,455 | $2.14 | 25 |
| 2020 Q3 | 3,298,108 | $7,682,631 | +$3,730,298 | $2.33 | 27 |
| 2020 Q2 | 1,702,221 | $3,419,000 | +$619,479 | $2.01 | 18 |
| 2020 Q1 | 1,628,998 | $1,184,000 | +$761,576 | $0.72 | 19 |
| 2019 Q4 | 539,706 | $1,429,005 | +$70,841 | $2.65 | 15 |
| 2019 Q3 | 509,321 | $1,716,054 | +$122,431 | $3.37 | 16 |
| 2019 Q2 | 460,755 | $2,759,096 | +$1,030,776 | $5.99 | 16 |
| 2019 Q1 | 287,260 | $2,124,000 | +$2,124,000 | $7.39 | 13 |